Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-15

Clinical Trial Update: AIMS Study: Improving HIV Treatment Adherence [NA]

View source ↗

Summary

The HIV treatment adherence trial 'AIMS' sponsored by Wageningen University has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Wageningen University | Conditions: HIV | NA | Status: COMPLETED